Member Login
  1. Stocks
    2. /
  2. CRISPR Therapeutics (NASDAQ: CRSP)
    3. /

NASDAQ:CRSP (CRISPR Therapeutics)

About CRSP

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • CRISPR Therapeutics (NASDAQ: CRSP) Latest News

    Investing Articles

    1 growth stock that could skyrocket over the next 10 years

    | Ben McPoland

    This investor is excited about the transformational potential of one growth stock that he's been eyeing up for his portfolio.

    Read more »

    Investing Articles

    After sliding 75%, this fascinating growth stock could be in bargain basement territory

    | Dr. James Fox

    This growth stock reached dizzying heights during the pandemic, but came down to earth with a bump. Is it a…

    Read more »

    Investing Articles

    After a 76% share price crash, is this now a bargain basement growth stock?

    | Ben McPoland

    This growth stock listed on the Nasdaq index was once trading for $200 but has now pulled back to $47.…

    Read more »

    Investing Articles

    How I’d invest £500 monthly to target a £56,400 second income for life

    | Dr. James Fox

    Consistently investing small sums of money in the stock market can lead to a substantial passive income. Dr James Fox…

    Read more »

    Female Doctor In White Coat Having Meeting With Woman Patient In Office
    Investing Articles

    1 incredible growth stock I can’t find on the FTSE 100

    | Dr. James Fox

    The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

    Read more »

    Investing Articles

    2 stocks to buy in the high potential gene editing space

    | Dr. James Fox

    Gene editing is one of the most exciting and interesting investment opportunities. So, here are two stocks to consider buying…

    Read more »

    The flag of the United States of America flying in front of the Capitol building
    Top Stocks

    Best US stocks to consider buying in February

    | The Motley Fool Staff

    We asked our freelance writers to reveal the top US stocks they’d buy in February, which included a familiar ride-sharing…

    Read more »

    Investing Articles

    39.5% below its target price, is this the most exciting growth stock?

    | Dr. James Fox

    Investors are always on the lookout for the next surging growth stock. So why could this US-listed company be the…

    Read more »

    Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
    Investing Articles

    This growth stock jumped 77%! I think it can go much higher

    | Dr. James Fox

    This growth stock has surged over the past month after the UK became the first country to approve a gene…

    Read more »

    Silhouette of a bull standing on top of a landscape with the sun setting behind it
    Investing Articles

    If I’d invested £1k in CRISPR Therapeutics shares on January 3, here’s what I’d have now!

    | Dr. James Fox

    This could be the most exciting growth stock out there. Dr James Fox takes a closer look at CRISPR Therapeutics…

    Read more »

    Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
    Investing Articles

    Growth stocks in focus: can buying CRISPR Therapeutics at $50 make me rich?

    | Dr. James Fox

    Dr James Fox takes a closer look at one of the most promising growth stocks, CRISPR Therapeutics. Could this gene-editing…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Here’s what Cathie Wood has been buying for her flagship Ark fund!

    | Dr. James Fox

    Expert stock picker Cathie Wood has been busy again this week. So let's take a look at the stocks Wood…

    Read more »